Acyclovir in immunocompromised patients with cytomegalovirus disease. A controlled trial at one institution.
D000212:Acyclovir; D000293:Adolescent; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006147:Guanine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007108:Immune Tolerance; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011024:Pneumonia, Viral / Q000188:drug therapy; D013997:Time Factors; D014184:Transplantation, Homologous
D000998:Antiviral Agents; D006147:Guanine; D000212:Acyclovir